Inventland Research Laboratories Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 1.00 M
- Company Age 6 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth 54.32%
- Profit Growth -3.37%
- Ebitda -7.14%
- Net Worth 72.17%
- Total Assets 36.66%
About Inventland Research Laboratories
Inventland Research Laboratories Private Limited (IRLPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 06 December 2018 (Six years and two months 21 days old ). Its registered office is in Solan, Himachal Pradesh, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Sovan Pal, Ankush Sharama, Vivek Kumar, and One other member serve as directors at the Company.
Company Details
- Location
Solan, Himachal Pradesh, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24100HP2018PTC007253
- Company No.
007253
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
06 Dec 2018
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Himachal Pradesh
Industry
Who are the key members and board of directors at Inventland Research Laboratories?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sovan Pal  | Director | 06-Dec-2018 | Current |
| Ankush Sharama | Director | 25-Mar-2019 | Current |
| Vivek Kumar | Director | 25-Mar-2019 | Current |
| Rohit Batish | Director | 15-Jul-2022 | Current |
Financial Performance of Inventland Research Laboratories.
Inventland Research Laboratories Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 54.32% increase. The company also saw a slight decrease in profitability, with a 3.37% decrease in profit. The company's net worth Soared by an impressive increase of 72.17%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Inventland Research Laboratories?
In 2023, Inventland Research Laboratories had a promoter holding of 55.36% and a public holding of 44.64%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Inventland Research Laboratories?
Unlock and access historical data on people associated with Inventland Research Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Inventland Research Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Inventland Research Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
